Silk Fibroin Microneedles for Transdermal Drug Delivery: Where Do We Stand and How Far Can We Proceed?

last updated: 2024-02-27
TitleSilk Fibroin Microneedles for Transdermal Drug Delivery: Where Do We Stand and How Far Can We Proceed?
Publication TypeReview Paper
Year of Publication2023
AuthorsQi Z. Z., Yan Z., Tan G. H. F., Jia T. S., Geng Y. Y., Shao H. Y., Kundu S. C., and Lu S. Z.
Abstract Text

Microneedles are a patient-friendly technique for delivering drugs to the site of action in place of traditional oral and injectable administration. Silk fibroin represents an interesting polymeric biomaterial because of its mechanical properties, thermal stability, biocompatibility and possibility of control via genetic engineering. This review focuses on the critical research progress of silk fibroin microneedles since their inception, analyzes in detail the structure and properties of silk fibroin, the types of silk fibroin microneedles, drug delivery applications and clinical trials, and summarizes the future development trend in this field. It also proposes the future research direction of silk fibroin microneedles, including increasing drug loading doses and enriching drug loading types as well as exploring silk fibroin microneedles with stimulation-responsive drug release functions. The safety and effectiveness of silk fibroin microneedles should be further verified in clinical trials at different stages.

JournalPharmaceutics
Volume15
Issue2
Pagination355
Date Published2023-01-20
PublisherMDPI
ISSN1999-4923
DOI10.3390/pharmaceutics15020355
URLhttps://www.mdpi.com/1999-4923/15/2/355
Keywordsclinical transformation, intelligently responsive, silk fibroin microneedles, transdermal delivery
RightsopenAccess
Peer reviewedyes
Statuspublished

Back to top